NASDAQ: AGRX Agile Therapeutics Anticipates Increased Growth In Q3 of 2022 Posted by Troy Media/TNW Media | Oct 21, 2022 Contact Details Matt Riley – Head of Investor Relations & Corporate Communications [email protected] Company Website https://agiletherapeutics.com/